BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 32364765)

  • 1. Roles of Exosomes from Mesenchymal Stem Cells in Treating Osteoarthritis.
    Wang J; Guo X; Kang Z; Qi L; Yang Y; Wang J; Xu J; Gao S
    Cell Reprogram; 2020 Jun; 22(3):107-117. PubMed ID: 32364765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis.
    Wu J; Kuang L; Chen C; Yang J; Zeng WN; Li T; Chen H; Huang S; Fu Z; Li J; Liu R; Ni Z; Chen L; Yang L
    Biomaterials; 2019 Jun; 206():87-100. PubMed ID: 30927715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role and therapeutic potential of MSC-derived exosomes in osteoarthritis.
    Bao C; He C
    Arch Biochem Biophys; 2021 Oct; 710():109002. PubMed ID: 34352243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular Vesicles from Mesenchymal Stem Cells as Potential Treatments for Osteoarthritis.
    Mohd Noor NA; Abdullah Nurul A; Ahmad Mohd Zain MR; Wan Nor Aduni WK; Azlan M
    Cells; 2021 May; 10(6):. PubMed ID: 34067325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of bone marrow mesenchymal stem cells-derived exosomes on osteoarthritis.
    Jin Y; Xu M; Zhu H; Dong C; Ji J; Liu Y; Deng A; Gu Z
    J Cell Mol Med; 2021 Oct; 25(19):9281-9294. PubMed ID: 34448527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cartilage Repair by Mesenchymal Stem Cell-Derived Exosomes: Preclinical and Clinical Trial Update and Perspectives.
    Taghiyar L; Jahangir S; Khozaei Ravari M; Shamekhi MA; Eslaminejad MB
    Adv Exp Med Biol; 2021; 1326():73-93. PubMed ID: 33629260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single‑cell sequencing, genetics, and epigenetics reveal mesenchymal stem cell senescence in osteoarthritis (Review).
    Tan D; Huang Z; Zhao Z; Chen X; Liu J; Wang D; Deng Z; Li W
    Int J Mol Med; 2024 Jan; 53(1):. PubMed ID: 37937669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Extracellular Vesicles from Adipose Tissue-Derived Mesenchymal Stem Cells in Primary Human Chondrocytes from Patients with Osteoarthritis.
    Guillén MI; Compañ A; Alcaraz MJ
    Methods Mol Biol; 2021; 2269():221-231. PubMed ID: 33687682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis?
    Mianehsaz E; Mirzaei HR; Mahjoubin-Tehran M; Rezaee A; Sahebnasagh R; Pourhanifeh MH; Mirzaei H; Hamblin MR
    Stem Cell Res Ther; 2019 Nov; 10(1):340. PubMed ID: 31753036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes derived from miR-92a-3p-overexpressing human mesenchymal stem cells enhance chondrogenesis and suppress cartilage degradation via targeting WNT5A.
    Mao G; Zhang Z; Hu S; Zhang Z; Chang Z; Huang Z; Liao W; Kang Y
    Stem Cell Res Ther; 2018 Sep; 9(1):247. PubMed ID: 30257711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes from embryonic mesenchymal stem cells alleviate osteoarthritis through balancing synthesis and degradation of cartilage extracellular matrix.
    Wang Y; Yu D; Liu Z; Zhou F; Dai J; Wu B; Zhou J; Heng BC; Zou XH; Ouyang H; Liu H
    Stem Cell Res Ther; 2017 Aug; 8(1):189. PubMed ID: 28807034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the therapeutic efficacy of mesenchymal stem cell-derived exosomes in osteoarthritis.
    Zhang Z; Zhao S; Sun Z; Zhai C; Xia J; Wen C; Zhang Y; Zhang Y
    Cell Mol Biol Lett; 2023 Sep; 28(1):75. PubMed ID: 37770821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes Derived From Human Urine-Derived Stem Cells Overexpressing miR-140-5p Alleviate Knee Osteoarthritis Through Downregulation of VEGFA in a Rat Model.
    Liu Y; Zeng Y; Si HB; Tang L; Xie HQ; Shen B
    Am J Sports Med; 2022 Mar; 50(4):1088-1105. PubMed ID: 35179989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoarthritic Subchondral Bone Release Exosomes That Promote Cartilage Degeneration.
    Wu X; Crawford R; Xiao Y; Mao X; Prasadam I
    Cells; 2021 Jan; 10(2):. PubMed ID: 33525381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MSC exosome as a cell-free MSC therapy for cartilage regeneration: Implications for osteoarthritis treatment.
    Toh WS; Lai RC; Hui JHP; Lim SK
    Semin Cell Dev Biol; 2017 Jul; 67():56-64. PubMed ID: 27871993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes and Stem Cells in Degenerative Disease Diagnosis and Therapy.
    Chang YH; Wu KC; Harn HJ; Lin SZ; Ding DC
    Cell Transplant; 2018 Mar; 27(3):349-363. PubMed ID: 29692195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research progress in the use of mesenchymal stem cells and their derived exosomes in the treatment of osteoarthritis.
    Yu H; Huang Y; Yang L
    Ageing Res Rev; 2022 Sep; 80():101684. PubMed ID: 35809775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose-Derived Mesenchymal Stromal Cells Treated with Interleukin 1 Beta Produced Chondro-Protective Vesicles Able to Fast Penetrate in Cartilage.
    Colombini A; Ragni E; Mortati L; Libonati F; Perucca Orfei C; Viganò M; Brayda-Bruno M; de Girolamo L
    Cells; 2021 May; 10(5):. PubMed ID: 34066077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Potential of Exosomes in Regenerative Medicine for Temporomandibular Joint Osteoarthritis.
    Lee YH; Park HK; Auh QS; Nah H; Lee JS; Moon HJ; Heo DN; Kim IS; Kwon IK
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes derived from bone marrow mesenchymal stem cells pretreated with decellularized extracellular matrix enhance the alleviation of osteoarthritis through miR-3473b/phosphatase and tensin homolog axis.
    Zhang Y; Qi G; Yan Y; Wang C; Wang Z; Jiang C; Jiang Z; Ma T; Zhang C; Yan Z
    J Gene Med; 2023 Aug; 25(8):e3510. PubMed ID: 36998238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.